Last 22.25 INR
Change Today -0.45 / -1.98%
Volume 2.6K
KILD On Other Exchanges
Symbol
Exchange
KILD is not on other exchanges.
As of 4:58 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

kilitch drugs (india) ltd (KILD) Snapshot

Open
22.80
Previous Close
22.70
Day High
23.10
Day Low
22.15
52 Week High
06/11/14 - 33.80
52 Week Low
02/25/14 - 16.90
Market Cap
294.4M
Average Volume 10 Days
3.6K
EPS TTM
-23.23
Shares Outstanding
13.2M
EX-Date
09/24/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KILITCH DRUGS (INDIA) LTD (KILD)

Related News

No related news articles were found.

kilitch drugs (india) ltd (KILD) Related Businessweek News

No Related Businessweek News Found

kilitch drugs (india) ltd (KILD) Details

Kilitch Drugs (India) Limited, a pharmaceutical company, manufactures and markets various formulations in solid, liquid, and parenteral dosage forms. The company manufactures antibacterial parenteral formulations and produces sterile liquid formulations. Its products include carbapenems, cephalosporins, beta-lactam antibiotics, steroids and hormones, gastrology products, non steroidal anti inflammatory drugs, anti malarials, aminoglycosides, anti-infectives, and other products. The company also provides contract manufacturing services, including product development and manufacturing services to pharmaceutical companies. In addition, it offers various services for the execution of the projects, which include turnkey services, project consultancy services, manufacturing and process equipment supplying, installation guidelines, commissioning the project, product know-how and process technology supplying, and training. The company exports its products to various countries, such as Algeria, Burundi, Cameroon, Eritrea, Ghana, Iraq, Nigeria, Russia, Senegal, Sri Lanka, Tchad, Niger, Ethiopia, Yemen, Sudan, Tanzania, and Uganda, as well as supplies products of various manufacturers. Kilitch Drugs (India) Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Founded in 1992

kilitch drugs (india) ltd (KILD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kilitch drugs (india) ltd (KILD) Key Developments

Kilitch Drugs (India) Limited Announces Audited Standalone Financial Results for the Fourth Quarter and Full Year Ended March 31, 2014

Kilitch Drugs (India) Limited announced audited standalone financial results for the fourth quarter and full year ended March 31, 2014. For the quarter, the company reported loss from operations before other income, interest & exceptional items of INR 43 million against INR 9.3 million for the same period of last year. Loss from ordinary activities before tax was INR 26.4 million against profit of INR 3.6 million for the same period of last year. Net loss for the period was INR 18 million or INR 1.39 per basic and diluted share against profit of INR 5.7 million or INR 0.43 per basic and diluted share for the same period of last year. Net sales/income from operations were INR 63 million against INR 78 million for the same period of last year. For the year, the company reported loss from operations before other income, interest & exceptional items of INR 52 million against profit of INR 49 million for the same period of last year. Profit from ordinary activities before tax was INR 10.7 million against INR 42.3 million for the same period of last year. Net profit for the period was INR 12 million or INR 0.89 per basic and diluted share against INR 33 million or INR 2.44 per basic and diluted share for the same period of last year. Net sales/income from operations were INR 142 million against INR 320 million for the same period of last year.

Kilitch Drugs (India) Limited to Report Fiscal Year 2014 Results on May 30, 2014

Kilitch Drugs (India) Limited announced that they will report fiscal year 2014 results on May 30, 2014

Kilitch Drugs (India) Limited, Board Meeting, May 30, 2014

Kilitch Drugs (India) Limited, Board Meeting, May 30, 2014. Agenda: To consider and approve the audited financial results of the company for the year ended March 31, 2014; and to consider constitution of various committees, if any, of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KILD:IN 22.25 INR -0.45

KILD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KILD.
View Industry Companies
 

Industry Analysis

KILD

Industry Average

Valuation KILD Industry Range
Price/Earnings 25.2x
Price/Sales 2.1x
Price/Book 0.2x
Price/Cash Flow 11.4x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KILITCH DRUGS (INDIA) LTD, please visit www.kilitch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.